文献速递间质性肺疾病

Rbms1通过稳定Sumo2 mRNA促进Smad4 SUMO化及成纤维细胞活化推动肺纤维化

Rbms1 promotes pulmonary fibrosis by stabilising Sumo2 mRNA to facilitate Smad4-SUMOylation and fibroblast activation.
PubMed 文献 · Eur Respir J · 2025-09-25

本研究旨在阐明RBMS1在肺纤维化中的作用及机制,利用小鼠原代肺成纤维细胞、成纤维细胞特异性Rbms1敲除与过表达小鼠模型及IPF患者肺样本进行系统研究。结果显示RBMS1在IPF患者肺及博来霉素诱导的小鼠纤维化病灶中高表达,促进肺成纤维细胞活化,而敲低Rbms1可减轻TGF-β1诱导的纤维化。机制上Rbms1结合Sumo2 3'非翻译区增强其mRNA稳定性,诱导Smad4的SUMO化,且去甲替林可药理抑制RBMS1改善小鼠肺纤维化。

要点

  • RBMS1在IPF患者肺及博来霉素诱导的小鼠纤维化病灶中高表达。
  • 成纤维细胞特异性敲除Rbms1可显著减轻博来霉素诱导的小鼠肺纤维化。
  • 去甲替林可药理抑制RBMS1并改善小鼠肺纤维化。

核心结论

  • RBMS1通过稳定Sumo2 mRNA促进Smad4的SUMO化及成纤维细胞活化,在肺纤维化中发挥调控作用,具有靶向抗纤维化治疗潜力。

研究设计与样本

  • 研究使用小鼠原代肺成纤维细胞(mPLFs)、成纤维细胞特异性Rbms1敲除与过表达小鼠模型以及IPF患者肺样本。

主要发现

  • RBMS1在IPF患者肺及小鼠博来霉素诱导的纤维化病灶中高表达。
  • TGF-β1刺激后mPLFs胞质中RBMS1表达升高。
  • Rbms1促进肺成纤维细胞活化,敲低Rbms1可减轻TGF-β1诱导的纤维化。
  • 体内过表达Rbms1损害肺功能并加重肺纤维化,而成纤维细胞特异性敲除Rbms1在博来霉素处理后显著减少纤维化。
  • Rbms1结合Sumo2 3'非翻译区增强其mRNA稳定性,并诱导Smad4的SUMO化,赖氨酸158被鉴定为关键SUMO化位点;敲低Sumo2可减轻Rbms1驱动的肺纤维化加重。

临床怎么用

  • 去甲替林可药理抑制RBMS1并改善小鼠肺纤维化,提示RBMS1可能作为抗纤维化治疗的靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The formation of myofibroblast foci constitutes a hallmark pathological feature of idiopathic pulmonary fibrosis (IPF), yet the mechanism remains elusive. RNA-binding motif single-stranded interacting protein 1 (RBMS1) is known to be essential for proliferation and cell cycle progression; however, its role in pulmonary fibrosis remains to be clarified. METHODS: This study aimed to systematically elucidate the role and underlying mechanism of RBMS1 in pulmonary fibrosis utilising mouse primary lung fibroblasts (mPLFs), fibroblast-specific Rbms1 deletion and overexpression mice models, and lung samples from IPF patients. RESULTS: RBMS1 was highly expressed in both IPF patient lungs and murine bleomycin-induced fibrotic lesions. Notably, elevated RBMS1 expression was observed in the cytoplasm of mPLFs following transforming growth factor (TGF)-β1 stimulation. Rbms1 promoted lung fibroblast activation, while knockdown of Rbms1 mitigated TGF-β1-induced fibrogenesis. In vivo, overexpression of Rbms1 impaired lung function and exacerbated pulmonary fibrosis, whereas fibroblast-specific deletion of Rbms1 exhibited a significant reduction in fibrosis post-bleomycin treatment. Mechanistically, Rbms1 binds to Sumo2 3' untranslated region, enhancing the mRNA stability. Furthermore, Rbms1 induced the SUMOylation of Smad4, with lysine 158 identified as a critical SUMOylation site. Meanwhile, Sumo2 knockdown alleviated the Rbms1-driven exacerbation of pulmonary fibrosis. Importantly, nortriptyline pharmacologically inhibited RBMS1 to ameliorate pulmonary fibrosis in mice. CONCLUSION: Collectively, our study sheds light on the regulatory role of RBMS1 in pulmonary fibrosis, highlighting its therapeutic potential for targeted antifibrotic strategies.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Guo Y, Wang Q, Zhang Y, et al. Rbms1 promotes pulmonary fibrosis by stabilising Sumo2 mRNA to facilitate Smad4-SUMOylation and fibroblast activation. Eur Respir J. 2025. PMID: 40473311. doi:10.1183/13993003.01667-2024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。